Increased population of high fluorescence 1F7 (CD26) antigen on T cells in synovial fluid of patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 23, Issue 12, 1996, Pages 2022-2026

  Mizokami, Akinari ^a   Eguchi, Katsumi ^a   Kawakami, Atsushi ^a   Ida, Hiroaki ^a   Kawabe, Yojiro ^a   Tsukada, Toshiaki ^a   Aoyagi, Takahiko ^b   Maeda, Kenji ^b   Morimoto, Chikao ^c   Nagataki, Shigenobu ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Ureshino Medical Center   (Japan)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

activated T cells; cd26; rheumatoid arthritis; synovial fluid; T cell migration

Indexed keywords

DIPEPTIDYL PEPTIDASE IV;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGENS, CD26; ANTIGENS, CD3; ARTHRITIS, RHEUMATOID; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MIDDLE AGED; SYNOVIAL FLUID; T-LYMPHOCYTES;

EID: 8044231312     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Nakao H, Eguchi K, Kawakami A, et al: Phenotypic characterization of lymphocytes infiltrating synovial tissue from patients with rheumatoid arthritis: Analysis of lymphocytes isolated from minced synovial tissue by immunofluorescent staining. J Rheumatol 1990;17:142-8.
2. Duke O, Panayi GS, Janossy G, Poulter LW, Tidman N: Analysis of T cell subsets in the peripheral blood and synovial fluid of patients with rheumatoid arthritis by means of monoclonal antibodies. Ann Rheum Dis 1983;42:357-61.
3. Cush JJ, Lipsky PE: Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum 1988;31:1230-8.
4. Reme T, Portier M, Frayssinoux F, et al: T cell receptor expression and activation of synovial lymphocyte tissue in patients with rheumatoid arthritis: Phenotyping of multiple synovial sites. Arthritis Rheum 1990;33:485-92.
5. Goto M, Miyasaka N, Nishioka K, Uchida S: T cytotoxic and helper cells are markedly increased, and T suppressor and inducer cells are markedly decreased in rheumatoid synovial fluids. Arthritis Rheum 1987;30:737-43.
6. Ueki Y, Eguchi K, Miyake S, Nagataki S, Tominaga Y: Increment of CD8+S6F1+ cells in synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 1994;53:816-22.
7. Hemler ME, Glass D, Coblyn JS, Jacobson JG: Very late activation antigens on rheumatoid synovial fluid T lymphocytes: Association with stages of T cell activation. J Clin Invest 1986;78:696-702.
8. Ueki Y, Eguchi K, Shimada H, et al: Increase in adhesion molecules on CD4+ cell subsets in synovial fluid from patients with rheumatoid arthritis. J Rheumatol 1994;21:1003-10.
9. Damle NK, Doyle LV: Ability of human T lymphocytes to adhere to vascular endothelial cells and to augment endothelial permeability to macromolecules in linked to their state of post-thymic maturation. J Immunol 1990;144:1233-40.
10. Pitzalis C, Kingsley G, Hasleard D, Panayi G: The preferential accumulation of helper-induced T lymphocytes in inflammatory lesions: Evidence for regulation by selective endothelial and homotypic adhesion. Eur J Immunol 1988;18:1397-404.
11. Matsuoka N, Eguchi K, Kawakami A, et al: Phenotypic characteristics of T cells interacted with synovial cells. J Rheumatol 1991;18:1137-42.
12. Shimada H, Eguchi K, Ueki Y, et al: Interleukin 4 increases human synovial cell expression of VCAM-1 and T cell binding. Ann Rheum Dis 1994;53:601-7.
13. Fox DA, Hussey RE, Fitzgerald KA, et al: Ta1, a novel 105KD human T cell activation antigen defined by a monoclonal antibody. J Immunol 1986;133:1250-6.
14. Hafler DA, Fox DA, Benjamin D, Weiner HL: Antigen reactive memory T cells are defined by Ta1. J Immunol 1986;137:414-8.
15. Morimoto C, Torimoto Y, Levinson G, et al: 1F7, a novel cell surface molecule, involved in helper function of CD4 cells. J Immunol 1989;143:3430-9.
16. Nakao H, Eguchi K, Kawakami A, et al: Increment of Ta1 positive cells in peripheral blood from patients with rheumatoid arthritis. J Rheumatol 1989;16:904-10.
17. Dang NH, Torimoto Y, Schlossman SF, Morimoto C: Human CD4 helper T cell activation: Functional involvement of two distinct collagen receptors, 1F7 and VLA integrin family. J Exp Med 1990;172:649-52.
18. Carsons S, Mosesson MW, Diamond HS: Detection and quantitation of fibronectin in synovial fluid from patients with rheumatic disease. Arthritis Rheum 1981;24:1261-7.
19. Scott DL, Wainwright AC, Walton KW, Williamson N: Significance of fibronectin in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 1981;40:142-53.
20. Miyake S, Yagita H, Maruyama T, Hashimoto H, Miyasaka N, Okumura K: Beta 1 integrin-mediated interaction with extracellular matrix proteins regulates cytokine gene expression in synovial fluid cells of rheumatoid arthritis patients. J Exp Med 1993;177:863-8.
21. Masuyama J, Berman JS, Cruikshank WW, Morimoto C, Center DM: Evidence for recent as well as long term activation of T cells migrating through endothelial cell monolayers in vitro. J Immunol 1992;148:1367-74.
22. Brezinschek RI, Lipsky PE, Galea P, Vita R, Oppenheimer-Marks N: Phenotypic characterization of CD4+ T cells that exhibit a transendothelial migratory capacity. J Immunol 1995;154:3062-77.
23. Muscat C, Bertotto A, Agea E, et al: Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients. Clin Exp Immunol 1994;98:252-6.
24. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-224.
25. Eguchi K, Otsubo T, Kawabe, et al: The remarkable proliferation of helper T cell subset in response to autologous thryocytes and intrathyroidal T cells from patients with Graves' disease. Clin Exp Immunol 1987;10:403-10.
26. Ueki Y, Eguchi K, Otsubo T, et al: Phenotypic analysis and concanavalin-A-induced suppressor cell dysfunction of intrathyroidal lymphocytes from patients with Graves' disease. J Clin Endocrinol Metab 1988;67:1018-24.
27. Hovdenes J, Gaudernack G, Kvien K, Egeland T, Mellbye OJ: A functional study of purified CD4+ and CD8+ cells isolated from synovial fluid of patients with rheumatoid arthritis and other arthritis. Scand J Immunol 1989;29:641-9.
28. Morimoto C, Letvin NL, Boyd AW, et al: The isolation and characterization of the human helper inducer T cell subset. J Immunol 1985;134:3762-9.
29. Eguchi K, Ueki Y, Shimomura C, et al: Increment in the Ta1+ cells in the peripheral blood and thyroid tissue of patients with Graves' disease. J Immunol 1989;142:4233-40.
30. Torimoto Y, Dang NH, Tanaka T, Prado C, Schlossman SF, Morimoto C: Biochemical characterization of CD26 (dipeptidyl peptidase IV): Functional comparison of distinct epitopes recognized by various anti-CD26 monoclonal antibodies. Mol Immunol 1992;29:183-92.
31. Dang NH, Torimoto Y, Deusch K, Schlossman SF, Morimoto C: Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathway. J Immunol 1990;144:4092-100.
32. Hegen M, Niedobitek G, Klein CE, Stein H, Fleischer B: The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. J Immunol 1990;144:2908-14.
33. Ulmer AJ, Mattern T, Feller AC, Heymann E, Flad HD: CD26 antigen is a surface dipeptidyl peptidase IV (DPP IV) as characterized by monoclonal antibodies clone TII-19-4-7 and 4EL1 C7. Scand J Immunol 1990;31:429-35.
34. Nagatsu T, Hino M, Fuyamada H, et al: New chromogenic substrates for X-prolyl-dipeptidylaminopeptidase. Anal Biochem 1976;74:466-73.
35. Kameoka J, Tanaka T, Nojima Y, Schlossman SF, Morimoto C: Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 1993;261:466-9.
36. Dang NH, Torimoto Y, Sugita Y, et al: Cell surface modulation of CD26 by anti-1F7 monoclonal antibody: Analysis of surface expression and human T cell activation. J Immunol 1990;145:3963-71.
37. Oppenheim JJ, Potter M: Immunity and inflammation. In: Oppenheim JJ, Rosenstreich DL, Potter M, eds. Cellular Functions in Immunity and Inflammation. Amsterdam: Elsevier/North Holland, 1981:1-28.
38. Galea P, Brezinschek R, Lipsky PE, Oppenheimer-Marks N: Phenotypic characterization of CD4-/αβTCR+ γδTCR+ T cells with a transendothelial migratory capacity. J Immunol 1994;153:529-42.
39. Pitzalis C, Kingsley GH, Covelli M, Meliconi R, Markey A, Panayi GS: Selective migration of the human helper-inducer memory T cell subset: Confirmation by in vivo cellular kinetic studies. Eur J Immunol 1991;21:369-76.
40. Iannone F, Corrigall VM, Kingsley GH, Panayi GS: Evidence for the continuous recruitment and activaton of T cells into the joints of patients with rheumatoid arthritis. Eur J Immunol 1994;24:2706-13.
41. Wilkinson PC: The locomotor capacity of human lymphocytes and its enhancement by cell growth. Immunology 1986;57:281-9.
42. Ratner SR, Jasti K, Heppner GH: Motility of murine lymphocytes during transit through cell cycle analysis by a new in vitro assay. J Immunol 1988;140:583-8.
43. Bonvoisin B, Cordier G, Revillard JP, Lejeune E, Bouvier M: Increased DNA and/or RNA content of synovial fluid cells in rheumatoid arthritis: A flow-cytometry study. Ann Rheum Dis 1984;43:222-1.
44. Hirose T, Goto M, Okumura K: HLA-DR, DQ and DP antigen expression in synovial fluid T lymphocytes in rheumatoid arthritis: Cell cycle analysis of HLA-DR positive T cells. J Rheumatol 1990;17:18-23.
45. dim mature memory T cells that are potent helpers for B cell differentiation. Arthritis Rheum 1992;35:1455-65.